Krill oil to improve muscle strength in adults with long-term health conditions
Official title: The Effect of Krill Oil Supplementation on Muscle Function in Adults With High-risk Long-term Conditions: a Randomized Controlled Pilot Study.
Run by University of Glasgow · NCT07130513 · Data updated 2026-11-12
This 12-week test will see if taking 4 g/day of krill oil improves muscle strength in adults with one or more long-term health conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Glasgow Academic / other |
| Locations | 2 sites (Glasgow, Lanarkshire and 1 other locations) |
| Status | Recruiting |
| Started | August 18, 2025 |
| Main results expected | July 30, 2026 |
| Study ends | July 30, 2026 |
| Registry record updated | October 2, 2025 |
| Trial ID | NCT07130513 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with one or more long-term conditions (for example rheumatoid arthritis, gout, type 2 diabetes, coronary heart disease, or stroke) who are not pregnant or breastfeeding and who do not regularly take fish oil or eat more than one portion of oily fish per week.
✕Probably not a fit
People on anticoagulant therapy, with a fish allergy, with a history of aortic stenosis or haemorrhagic stroke, who are pregnant or breastfeeding, or who already take fish oil/krill supplements or regularly eat oily fish are unlikely candidates and may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind 12-week pilot trial will enroll 30 adults who will receive either 4 g/day krill oil (Superba™) or 4 g/day placebo vegetable oil. Participants will be asked to maintain their usual diet and activity while researchers measure grip strength and collect dietary and activity data using the EPIC FFQ and IPAQ, plus a weekly fish consumption log. Eligibility excludes people with cancer, neurocognitive disorders, certain cardiovascular risks (for example aortic stenosis or prior haemorrhagic stroke), current anticoagulant therapy, pregnancy or breastfeeding, fish allergy, or regular oily fish or fish oil use. The pilot will test feasibility and provide initial effect-size data to inform a larger trial.
Why it matters
Potential benefit: If effective, krill oil could modestly improve grip strength and physical function in people with chronic conditions.
How similar studies have gone: Previous trials of omega-3 supplements have produced mixed results for muscle strength, and krill oil specifically has limited prior trial evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women aged ≥18 years who are in the high-risk long-term condition group (having one or more LTCs, including rheumatoid arthritis, gout, type 2 diabetes, coronary heart disease, and stroke \[including transient ischemic attack, TIA\]). Exclusion Criteria: * Participants are diagnosed with and being treated for any type of cancer. * Presence of neurocognitive disorders or any health condition affecting memory (e.g., Alzheimer's disease, dementia). * Aortic stenosis, history of haemorrhagic stroke, or presence of aneurysms. * Current anticoagulant therapy. * Use of any muscle mass supplements or presence of physiological conditions such as pregnancy or breastfeeding. * History of allergy to fish or fish oil. * Regular consumption of more than one portion of oily fish per week, or use of fish oil or krill oil supplements.
Where it's running
-
Lab 242, Sir James Black Building, University of Glasgow
Glasgow, Lanarkshire, United Kingdom Recruiting -
University of Glasgow
Glasgow, Lanarkshire, United Kingdom Not yet recruiting
Study contacts
- Study coordinator: Professor Stuart Gray
- Email: stuart.gray@glasgow.ac.uk
- Phone: +441413302569
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Protein supplements with or without spices to protect muscle for people on GLP-1 weight loss meds
This pilot test checks whether daily whey protein, with or without mixed spices, helps preserve muscle mass and strength in adults using GLP-1 weight-loss medicines.
-
Finding the Fair-ly Normal Grip
This study tests how the Dinomometer measures grip strength in a broad group of Minnesota children and adults to create normal reference values.
-
Urolithin A (Mitopure) to improve muscle strength in middle-aged adults
This study will test whether taking Mitopure (urolithin A) once daily for six months can improve muscle strength and performance in healthy 40–65-year-olds with low activity and lower aerobic fitness.
-
Randomized comparison of whole-body vibration plus usual care versus usual care to improve muscle health in older adults
This study will test whether adding a four-week, three-times-weekly whole-body vibration program to usual care helps pre-frail and mildly frail adults aged 65 and older improve muscle mass, strength, and function.
-
Omega-3 supplements to address diet-driven health disparities
This test will see if daily omega-3 supplements lower inflammation and improve heart-related blood markers in healthy non-Hispanic Black and White adults with different FADS gene types.
-
Effects of Omega-3 Fatty Acids on Brain Health in Soccer Players
This study is testing if omega-3 fatty acids can help protect the brains of young soccer players who have had minor head impacts.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.